Testing a New Imaging Agent to Identify Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to HER2-positive Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of the Combination of TQ-B211 Plus Docetaxel in Patients With HER2-positive MBC.
- Status
- UNKNOWN
- Phase
- PHASE3
ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility of a New Technology for Isolating Circulating Tumour Cells
- Status
- UNKNOWN
- Phase
- NA
Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1